Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer

Genes Chromosomes and Cancer

Volumn 20, Issue 2, 1997, Pages 140-147

  Ueda, Takeshi ^a   Komiya, Akira ^a   Emi, Mitsuru ^b   Suzuki, Hiroyoshi ^a   Shiraishi, Taizo ^c   Yatani, Ryuichi ^c   Masai, Motoyuki ^d   Yasuda, Kosaku ^a   Ito, Haruo ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MICROSATELLITE DNA;

ALLELE; ARTICLE; CHROMOSOME 18Q; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CHROMOSOMES, HUMAN, PAIR 18; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

MARTES PENNANTI;

EID: 0030955283     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199710)20:2<140::AID-GCC4>3.0.CO;2-3     Document Type: Article

References (47)

1. Bergerheim USR, Kunimi K, Collins VP, Ekman P (1991) Deletion mapping of chromosome 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3:215-220.
2. Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB (1993) Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873.
3. Chenevix-Trench G, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Persons PG, Friedlander M, Khoo SK (1992) Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 7:1059-1065.
4. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA, Vogelstein B (1994) The DCC gene: Structural analysis and mutations in colorectal carcinomas. Genomics 19:525-531.
5. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ (1996) Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56:1142-1145.
6. Cropp CS, Lidereau R, Campbell G, Champene MH, Callahan R (1990) Loss of heterozygosity on chromosome 17 and 18 in breast carcinoma: Two additional regions identified. Proc Nad Acad Sci USA 87:7737-7741.
7. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG, Thibodeau SN (1996) Allelic imbalance and microsatellite instability in prostate adenocarcinoma. Cancer Res 56:4475-1482.
8. Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ (1991) Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene 6:311-315.
9. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B (1990) Identification of a chromosomal 18q gene that is altered in colorectal cancers. Science 247:49-56.
10. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ (1993) Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostate cancer. Cancer Res 53:2723-2727.
11. Gao X, Zacharek A, Grignon DJ, Sakr W, Powell IJ, Porter AT, Honn KV (1995) Localization of potential tumor suppressor loci to a <2 Mb region on chromosome 17q in human prostate cancer. Oncogene 11:1241-1247.
12. Gray IC, Philips SMA, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK (1995) Loss of the chromosome region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803.
13. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994) The 1993-1994 Généthon human genetic linkage map. Nature Genet 7:246-335.
14. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redson MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670-4675.
15. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996a) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
16. Hahn SA, Hoque ATMS, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hurban RH, Kern SE (1996b) Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56:490-494.
17. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ (1992) Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52:6525-6530.
18. Höhne MW, Halatsch M-E, Kahl GF, Weinel RJ (1992) Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 52:2616-2619.
19. Ittmann M (1996) Allelic loss on chromosome 10 in prostate cancer. Cancer Res 56: 2143-2147.
20. Kim SK, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R, Mao L (1996) DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 56:2519-2521.
21. Komiva A, Suzuki H, Aida S, Yatani R, Shimazaki J (1995) Mutational analysis of CDKN2/(CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer. Jpn J Cancer Res 86:622-625.
22. Komiva A, Suzuki H, Ueda T, Yatani R, Mitsuru Emi, Haruo Ito, Shimazaki J (1996) Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosom Cancer 17:245-253.
23. Kunimi K, Bergerheim USR, Larsson I-L, Ekman P, Collins VP (1991) Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536.
24. Latil A, Baron J-C, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, Duc AL, Rouesse J, Lidereau R (1994) Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q. Genes Chromosom Cancer 11:119-125.
25. Latil A, Fournier G, Cussenot O, Lidereau R (1996) Differential chromosome allelic imbalance in the progression of human prostate cancer. J Urol 156:2079-2083.
26. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R (1994) Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance. Genes Chromosom Cancer 10:151-159.
27. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ (1995) Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 55:5390-5395.
28. Miyake S, Nagai K, Yoshino K, Oto M, Endo M, Yuasa Y (1994) Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 54:3007-3010.
29. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokawa K, Takahashi T, Takahashi T (1996) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56:2718-2720.
30. Nigro JM, Cho KR, Fearon ER, Kern SE, Ruppert JM, Oliner JD, Kinzler KW, Vogelstein B (1991) Scrambled exons. Cell 64:607-613.
31. Prout GR (1973) Diagnosis and staging of prostatic carcinoma. Cancer 32:1096-1103.
32. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B (1996) Mad-related genes in the human. Nature Genet 13:347-349.
33. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero Jr RA, Meltzer PS, Hahn SA, Kern SE (1996) DPC4 gene in various tumor types. Cancer Res 56:2527-2530.
34. Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J (1994) Frequent allelic losses on chromosome 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 54:5643-5648.
35. Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J (1993) Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Molec Biol 46:759-765.
36. Suzuki H, Aida S, Akimoto S, Igarashi T, Yatani R, Shimazaki J (1994) State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer. Jpn J Cancer Res 85:847-852.
37. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, Shimazaki J (1995a) Localization of a tumor suppressor gene-associated with progression of human prostate cancer within a 1.2 Mb region 8p22-p21.3. Genes Chromosomes Cancer 13:168-174.
38. Suzuki H, Komiya A, Aida S, Akimoto S, Shiraishi T, Yatani R, Igarashi T, Shimazaki J (1995b) Microsatellite instability and other molecular abnormalities in human prostate cancer. Jpn J Cancer Res 86:956-961.
39. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi I, Yatani R, Shimazaki J (1996) Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosom Cancer 17:225-233.
40. Tikahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau N, Jenkins RB (1995) Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55:4114-4119.
41. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JKY, Markowitz SD, Hamilton SR, Kern SE, Kinzler KW, Vogelstein B (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature Genet 13:343-346.
42. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S (1992) Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52:3099-3102.
43. van Kessel AG, Straub RE, Silverman GA, Gerken S, Overhauser J (1994) Report of the second international workshop on human chromosome 18 mapping. Cytogenet Cell Genet 65:142-163.
44. Vozelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smith AMM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Eng J Med 319:525-532.
45. Williams BJ, Jones E, Zhu XL, Steele MR, Stephenson RA, Rohr R, Brothman AR (1996) Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 155:720-725.
46. Wingo PA, Tong T, Bolden S (1995) Cancer Statistics; 1995. CA Cancer J Clin 45:8-30.
47. Zenkluzen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ (1994) Loss of heterozygosity in human primary prostate carcinomas: possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373.